HansBiomed Corporation (042520) — Cash Flow Quality Index
HansBiomed Corporation (042520) has a Cash Flow Quality Index of 1.70x as of June 2024. Operating cash flow of ₩159.13 Million exceeds net income of ₩93.69 Million, indicating high earnings quality where cash backs reported profits. Explore HansBiomed Corporation strategic investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
HansBiomed Corporation Cash Flow Quality Index (2012–2022)
Historical Cash Flow Quality Index for HansBiomed Corporation across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check HansBiomed Corporation tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for HansBiomed Corporation (2012–2022)
Year-by-year earnings quality comparison for HansBiomed Corporation. For live market cap and the full company financial profile, see 042520 company net worth.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -0.69x | ₩-4.27 Billion | ₩6.15 Billion | ▼ -188.7% |
| 2019 | 0.78x | ₩7.71 Billion | ₩9.85 Billion | ▼ -37.4% |
| 2018 | 1.25x | ₩5.20 Billion | ₩4.16 Billion | ▲ +75.0% |
| 2017 | 0.72x | ₩5.60 Billion | ₩7.83 Billion | ▲ +1179.4% |
| 2016 | -0.07x | ₩-316.10 Million | ₩4.77 Billion | ▼ -109.4% |
| 2015 | 0.71x | ₩3.47 Billion | ₩4.91 Billion | ▲ +19.8% |
| 2014 | 0.59x | ₩2.06 Billion | ₩3.50 Billion | ▼ -13.2% |
| 2013 | 0.68x | ₩2.33 Billion | ₩3.43 Billion | ▲ +14.0% |
| 2012 | 0.60x | ₩1.50 Billion | ₩2.52 Billion | — |